About: Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 October 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2004 (uk) artículu científicu espublizáu n'ochobre de 2004 (ast) scientific article published on 01 October 2004 (en)
publication date	wds:Q80809839-8EED842D-1AE4-49F4-AC9E-B79B5A3D4E73
publication date	2004-10-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q80809839-8E0402DD-7230-4DAA-B911-E84F257CDD12
cites work	p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia
author name string	wds:Q80809839-02E73CAB-8EA5-48C1-A565-66E630081076 wds:Q80809839-1A0A079A-9582-46C3-9175-F46338A86130 wds:Q80809839-6BC18C18-D532-4AB3-A835-0A3BE14489F6 wds:Q80809839-A4D64117-0E6C-484D-8BB8-82413B9E22BB wds:Q80809839-B66E0D81-6036-4CE8-B623-6D8F1B60E62E wds:Q80809839-BAA46373-992C-45A1-9359-4CCB4DB26703
author name string	Hartmut Döhner Norbert Schweifer Christian Stratowa Norbert Kraut Christian Haslinger Roger Abseher
rdfs:label	Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (en) Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (nl)
skos:prefLabel	Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (en) Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (nl)
name	Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (en) Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (nl)
author	wds:Q80809839-82B9DBC8-AD7C-47D3-8D13-D37127E38A5A wds:Q80809839-A508DF8B-769E-4533-B559-2DEB1564CE79
author	Peter Lichter Stephan Stilgenbauer
title	wds:Q80809839-6A770891-B712-4C09-BDB5-7CFFB7A723E9
title	Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status (en)
page(s)	wds:Q80809839-68107072-7F53-4078-9323-97B9D01093FA
page(s)	3937-3949
instance of	wds:Q80809839-4D91ECFB-D254-4846-BDB4-F1CAAE708321
instance of	scholarly article
main subject	wds:Q80809839-E3A54D03-133F-4718-9E0F-BA14890AAACE
main subject	B-cell chronic lymphocytic leukemia
PubMed ID	wds:Q80809839-33BF1A93-491A-4470-8978-B655F05DCB7B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15459216
PubMed ID	15459216
published in	wds:Q80809839-FDFD56B6-ABC2-4E33-BA0D-6E3844AAE3FA
published in	Journal of Clinical Oncology
issue	wds:Q80809839-8C9B8546-DEC8-4018-B1B8-48BF9484ECD7
volume	wds:Q80809839-4215485E-7FB9-46A5-AE44-F4381AC362B6
issue	19
volume	22
DOI	wds:Q80809839-92B4AD0C-7B86-4DF4-8A96-0E10603626BA
DOI	http://dx.doi.org/10.1200/JCO.2004.12.133
DOI	10.1200/JCO.2004.12.133
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80809839
is cites work of	Inhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development. Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks Suppression of survival signalling pathways by the phosphatase PHLPP Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go HtrA serine proteases as potential therapeutic targets in cancer Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia Regulatory network reconstruction reveals genes with prognostic value for chronic lymphocytic leukemia ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks Heat-shock factor 2 is a suppressor of prostate cancer invasion. Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease SAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL. The projection score--an evaluation criterion for variable subset selection in PCA visualization Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling. A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia Chronic lymphocytic leukaemia Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens. Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia Clinical proteomics: present and future prospects. Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes Developing Molecular Signatures for Chronic Lymphocytic Leukemia Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20. Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software